Suchergebnisse
Suchergebnisse:
Our laboratory uses genomic approaches to discover the causes of cancer, with a focus on lung and colon cancers. We then apply these genomic findings to understand these cancers and to begin the path to new cancer treatments (genome-inspired discovery).
- Lab and Collaborative Articles
Lab and Collaborative Articles - Matthew Meyerson - Meyerson...
- Review Articles
Review Articles - Matthew Meyerson - Meyerson Lab - Cancer...
- Scientific Staff
Scientific Staff - Matthew Meyerson - Meyerson Lab - Cancer...
- Lab Alumni
Lab Alumni - Matthew Meyerson - Meyerson Lab - Cancer...
- People
People - Matthew Meyerson - Meyerson Lab - Cancer Genomics...
- Publications
Total Research Publications: all Meyerson Lab publications,...
- Lab and Collaborative Articles
Meyerson is a principal investigator in The Cancer Genome Atlas project (TCGA) of the National Institutes of Health, leads the lung cancer disease working group of TCGA, and is co-chair of TCGA’s executive committee.
Matthew Langer Meyerson (born June 4, 1963) is an American pathologist and the Charles A. Dana Chair in Human Cancer Genetics at the Dana-Farber Cancer Institute. He is also director of the Center for Cancer Genomics at the Dana-Farber Cancer Institute, and the Director of Cancer Genomics at the Broad Institute of MIT and Harvard.
Matthew Meyerson began his research group at Dana-Farber Cancer Institute in 1998 with the goal of using genomic approaches to understand the causes of human cancer, with a focus on lung cancer, and to apply this new understanding to the development of effective treatments that kill cancer cells while sparing healthy cells. Our research uses ...
9. Apr. 2021 · “Clearly, we don't know enough about cancer yet,” says Dr. Meyerson, director of the Center for Cancer Genomics at DFCI and a professor of genetics and medicine at DFCI and Harvard Medical School. “There's still a big knowledge gap in the genome. If we knew enough, we could treat every cancer.”
- Carrie Printz
- 09 April 2021
- 2021
- 127, Issue7
Matthew Langer Meyerson. Professor of Genetics and Medicine. We strive to discover genomic and infectious causes for human cancers. We then seek to apply these discoveries to understand mechanisms of cancer pathogenesis, and to improve cancer diagnosis and treatment.
Articles 1–20. Professor of Genetics and Medicine, Harvard Medical School - Cited by 327,907 - Cancer biology - genetics - and drug discovery.
